Veradermics (MANE) Total Current Liabilities (2024 - 2026)

Veradermics (MANE) has 3 years of Total Current Liabilities data on file, last reported at $6.7 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities changed N/A year-over-year to $6.7 million; the trailing twelve-month figure through Mar 2026 stood at $6.7 million (changed N/A YoY), and the FY2025 full-year result was $9.2 million, up 93.98% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $6.7 million, down from $9.2 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $9.2 million in Q4 2025 and bottomed at $4.7 million in Q4 2024.
• The 3-year median for Total Current Liabilities is $6.7 million (2026), against an average of $6.9 million.
• Peak annual rise in Total Current Liabilities reached 93.98% in 2025, while the deepest fall reached 93.98% in 2025.
• A 3-year view of Total Current Liabilities shows it stood at $4.7 million in 2024, then soared by 93.98% to $9.2 million in 2025, then fell by 26.62% to $6.7 million in 2026.
• The last three Total Current Liabilities figures came in at $6.7 million (Q1 2026), $9.2 million (Q4 2025), and $4.7 million (Q4 2024), per Business Quant data.

Peer Comparison